HTB – HIV Treatment Bulletin for Bosnia and Herzegovina, Croatia, Montenegro and Serbia

HTB-COVER.png

Project name:     HTB – HIV Treatment Bulletin for Bosnia and Herzegovina, Croatia, Montenegro and Serbia

Duration:     One year (May 2012 -  June 2013.)

Donors:     Gilead Pharmaceuticals and Merck Sharp & Dohme Pharmaceuticals

Partners:     International HIV Partnerships and HIV i-Base UK

Project goal:     Establishing of the bulletin as a reliable and comprehensive source of information on relevant HIV treatment developments all around the World.

Description:     The Bulletin is a unique source of up-to-date information in BCMS language on HIV and related conditions which gathers current data derived from well-recognized journals and meetings in reader-friendly concentrated summaries. It also provides a means for local sharing of data and information on HIV/AIDS with presentations of local cases.

Most of the Bulletin’s information will be translated into BCMS from HIV Treatment Bulletin, a not-for-profit community journal published by HIV i-Base (UK) that reviews the most important advances worldwide in the clinical management of HIV and access to treatment.

Local information will also be included with current information on available drugs and diagnostics, workarounds for those not yet available in Bosnia and Herzegovina, Croatia, Montenegro and Serbia, case studies and discussions with physicians, and treatment Q & A's.

Results:    Three issues of HTB published and distributed to all relevant experts in the four countries, but also to everyone else interested in the topic.

System for publishing further issues established.

Funcitioning mechanisms for exchange of information and cooperation between the four countries
 

      

Five year report

APR